Toll Biotech Co., Ltd.(Beijing)
Latest round
- Series A
Last raised
- Sep 2025
Total raised
- $16M
Investors
- 8
About Toll Biotech Co., Ltd.(Beijing)
(Beijing) is a technology company that provides research and development of new drugs for autoimmune diseases. The founder of the company, Professor Yin Hang, is the Associate Dean, School of Pharmacy, Tsinghua University. The company also was awarded as Zhongguancun High-Tech Enterprises. The company has launched three technology platforms which are new drug development platform, preclinical development platform and clinical development platform. The company's product pipeline can be applied to rheumatoid arthritis, lupus erythematosus, viral infections, Parkinson's, etc. The company has cooperation with Tsinghua University, Peking University, Chinese Academy of Sciences and etc. The company will focus on the development of new drugs for autoimmune diseases and the construction of the company's research and development center and drug development platform to further strengthen the company's research and development strength and expand its pipeline.
Who invested in Toll Biotech Co., Ltd.(Beijing)
8 investors across 3 rounds
See all investors in Toll Biotech Co., Ltd.(Beijing)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Toll Biotech Co., Ltd.(Beijing)
Who invested in Toll Biotech Co., Ltd.(Beijing)?
Toll Biotech Co., Ltd.(Beijing) has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Toll Biotech Co., Ltd.(Beijing) raised?
Toll Biotech Co., Ltd.(Beijing) has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Toll Biotech Co., Ltd.(Beijing) last raise money?
Toll Biotech Co., Ltd.(Beijing)'s most recent round on record is a Series A, in Sep 2025.
What does Toll Biotech Co., Ltd.(Beijing) do?
(Beijing) is a technology company that provides research and development of new drugs for autoimmune diseases.
Where is Toll Biotech Co., Ltd.(Beijing) headquartered?
Toll Biotech Co., Ltd.(Beijing) is headquartered in Beijing, China.
Which VCs invest in companies like Toll Biotech Co., Ltd.(Beijing)?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Toll Biotech Co., Ltd.(Beijing)'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Toll Biotech Co., Ltd.(Beijing)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.